NCT02023073 Determination of Physical Parameters Relevant to Ophthalmic Lasers
| NCT ID | NCT02023073 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sheba Medical Center |
| Condition | Healthy Volunteers |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2018-07-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2018-07-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The use of lasers in medicine in general, and diagnosis and treatment in ophthalmology in particular, increased significantly. Making retinal surgery using lasers have become increasingly common. The goal: to diagnose eye diseases safely
Eligibility Criteria
Inclusion Criteria: * Age 18-40 years * Refraction up to ±0.25D, * General good health * Written informed consent to participate in the study. Exclusion Criteria: * known current ophthalmic pathology * known past ophthalmic pathology (including LASIK surgery) * eye glasses or contact lenses
Contact & Investigator
Ygal Rotenstreich, MD
PRINCIPAL INVESTIGATOR
Sheba Medical Center
Frequently Asked Questions
Who can join the NCT02023073 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Healthy Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02023073 currently recruiting?
Yes, NCT02023073 is actively recruiting participants. Contact the research team at ygal.rotenstreich@sheba.health.gov.il for enrollment information.
Where is the NCT02023073 trial being conducted?
This trial is being conducted at Tel Litwinsky, Israel.
Who is sponsoring the NCT02023073 clinical trial?
NCT02023073 is sponsored by Sheba Medical Center. The principal investigator is Ygal Rotenstreich, MD at Sheba Medical Center. The trial plans to enroll 20 participants.